Axsome Therapeutics, Inc. · NASDAQ:AXSM
Jeffs Roger sold 572 Axsome Therapeutics, Inc. shares (Form 4)
Traded Jun 10 to Jun 11, 2026 · Filed Jun 11, 2026
From Jun 10 to Jun 11, 2026, Jeffs Roger (Director) sold 572 Axsome Therapeutics, Inc. shares at an average US$247.65 for US$142K under a trading plan, leaving 58,367 shares. Filed Jun 11, 2026 (Form 4).
- Sold
- 572 shares
- Price
- US$247.65 average (US$246.18 to US$249.12)
- Value
- US$142K
- Holding after
- 58,367 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Common Stock | Sale | 286 | US$246.18 | 58,653 | Direct |
| Jun 11, 2026 | Common Stock | Sale | 286 | US$249.12 | 58,367 | Direct |
Source
Related
- Axsome Therapeutics, Inc.
- Jeffs Roger
- Axsome Therapeutics, Inc. shareholders
- Form 4 · Jeffs Roger · Jun 10, 2026
- Form 4 · Jacobson Mark L. · Sep 3, 2026
- Form 4 · Tabuteau Herriot · Aug 7, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026
- Form 4 · Tabuteau Herriot · Jul 1, 2026
- Form 4 · Mahony Susan · Jun 10, 2026